Project 2

项目2

基本信息

项目摘要

Aggregation and fibrillation of SODl have been implicated in disease mechanisms of Amyotrophic Lateral Sclerosis (ALS), and it is a major new goal of this Program Project renewal to develop better biological assays to study the toxicity of these multimeric forms of SODl in systems that will be more relevant to the disease in humans. In Project 2 we further develop and use a human cell culture system that closely models important cell biological aspects of motor neuron degeneration¿our recently developed human embryonic stem cell-derived motor neuron (HESC-MN) system. The cells have distinct advantages over other model systems as they represent the major cell type that degenerates in ALS and they are fully human. The cells express identifying neuronal markers, exhibit electrophysiological function typical for mature motor neurons, and can be co-cultured with other neuronal and non-neuronal cells. Transfection of these cells to express ALS-SODl proteins causes deleterious effeds on cell survival and morphology. Importantly for this project, we have recently shown that exogenously added ALS-SODl protein multimers are taken up quite well. We will utilize these cells to study the toxicity of SODl protein multimers and aggregates at different stages of their formation and relate it to the progression of motor neuron degeneration. This research plan outlines a highly collaborative, step-by-step approach to evaluate spontaneous and induced mutant and WT SODl aggregate formation in motor neurons, followed by an investigation of the consequences of SODl aggregates on neurodegenerative mechanisms and, finally, by using pharmacological inhibitors of SODl aggregation to investigate whether reduced SODl aggregation can prevent motor neuron death.
肌萎缩侧索硬化症的发病机制与SOD1的聚集和纤颤有关 硬化症(ALS),这是该计划项目更新的一个主要新目标,开发更好的生物检测方法来 研究这些多聚体SOD1在与疾病更相关的系统中的毒性 人类。在项目2中,我们进一步开发和使用了人体细胞培养系统,该系统可以对重要细胞进行近距离建模 运动神经元变性的生物学方面?我们最近开发的人类胚胎干细胞来源 运动神经元(HESC-MN)系统。单元格与其他模型系统相比具有明显的优势,因为它们代表 肌萎缩侧索硬化症中退化的主要细胞类型,它们完全是人类。这些细胞表达识别神经元 标记物表现出成熟运动神经元的典型电生理功能,并可与 其他神经元和非神经元细胞。转染这些细胞表达ALS-SOD1蛋白引起 对细胞存活和形态的有害影响。对这个项目来说很重要的是,我们最近展示了 外源添加的ALS-SOD1蛋白多聚体被很好地吸收。我们将利用这些细胞来研究 SOD1蛋白多聚体和聚集体形成不同阶段的毒性及其与细胞毒性的关系 运动神经元变性的进展。该研究计划概述了高度协作、循序渐进的 运动神经元自发和诱导突变及WT SOD1聚集体形成的评价方法, 随后研究了SOD1聚集体对神经退行性机制的影响, 最后,通过使用SODl聚集的药物抑制剂来研究SODl减少 聚集可以防止运动神经元死亡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTINA H WIEDAU-PAZOS其他文献

MARTINA H WIEDAU-PAZOS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTINA H WIEDAU-PAZOS', 18)}}的其他基金

Project 1
项目1
  • 批准号:
    8452702
  • 财政年份:
    2005
  • 资助金额:
    $ 23.12万
  • 项目类别:
Project 2
项目2
  • 批准号:
    7961931
  • 财政年份:
    2005
  • 资助金额:
    $ 23.12万
  • 项目类别:
Gsk-3beta & beta-Catenin in pathophysiology of FTDP-17
Gsk-3beta
  • 批准号:
    7116985
  • 财政年份:
    2004
  • 资助金额:
    $ 23.12万
  • 项目类别:
Gsk-3beta & beta-Catenin in pathophysiology of FTDP-17
Gsk-3beta
  • 批准号:
    6864862
  • 财政年份:
    2004
  • 资助金额:
    $ 23.12万
  • 项目类别:
Gsk-3beta & beta-Catenin in pathophysiology of FTDP-17
Gsk-3beta
  • 批准号:
    7440145
  • 财政年份:
    2004
  • 资助金额:
    $ 23.12万
  • 项目类别:
Gsk-3beta & beta-Catenin in pathophysiology of FTDP-17
Gsk-3beta
  • 批准号:
    6722712
  • 财政年份:
    2004
  • 资助金额:
    $ 23.12万
  • 项目类别:
Gsk-3beta & beta-Catenin in pathophysiology of FTDP-17
Gsk-3beta
  • 批准号:
    7254708
  • 财政年份:
    2004
  • 资助金额:
    $ 23.12万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 23.12万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 23.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 23.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 23.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 23.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 23.12万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 23.12万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 23.12万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 23.12万
  • 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
  • 批准号:
    2706416
  • 财政年份:
    2022
  • 资助金额:
    $ 23.12万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了